Patients with hereditary Rb exhibit a markedly heightened and earlier-onset susceptibility to both cutaneous melanoma and non-melanoma skin cancer (NMSC), with median ages at diagnosis approximately two decades younger than those observed in nonhereditary counterparts [11]. This evidence concerns the gene RB1 and cutaneous melanoma.